Abstain From These Sorts Of Techniques That Could Wreck The CH5424802 Once And For All

Patients with grades 3 or 4 peripheral neuropathy or ileus were switched from vincristine to vinblastine. Dexamethasone was temporarily discontinued or dose-reduced for grades 3 or 4 myopathy. Patients who achieved complete remission (CR) were referred for allogeneic HSCT once a matched related or unrelated donor was identified. Depending on age and co-morbidities, patients were offered either myeloablative or reduced intensity conditioning (RIC) regimen according to the decision of the transplant team. Myeloablative HSCT preparative regimens consisted of cyclophosphamide (60?mg/kg?��?2) plus total body irradiation (TBI, 12?Gy in 6 fractions) or fludarabine (50?mg/kg/d?��?4), busulfan (3��2?mg/kg/d?��?4) plus total body irradiation (4?Gy in two fractions). The RIC regimen consisted of fludarabine (30?mg/kg/d?��?4), busulfan (3��2?mg/kg/d?��?2) plus TBI (2?Gy in a single fraction). GVHD prophylaxis consisted primarily of ciclosporin and methotrexate; four http://www.selleck.cn/products/Verteporfin(Visudyne).html patients received alemtuzumab. CR was defined as attainment of a normocellular marrow with http://www.selleckchem.com/products/ch5424802.html phase of the induction chemotherapy. Overall survival (OS) was defined as the time from initiation of induction chemotherapy until death or last follow-up. Event-free survival (EFS) was defined as the time from diagnosis until relapse, death or last follow-up. Toxicities were determined by NCI-CTC Version 4, while Eastern Cooperative Oncology Group (ECOG) criteria were used to determine performance status. Physical deconditioning was defined as a decrease in performance status to ECOG 3 or 4. The cumulative dose of chemotherapy drug delivered during the intensification phase was calculated as a percentage of the intended dose from the start of intensification up to the time of HSCT, relapse or end of intensification. Descriptive statistics were reported as median and range for continuous variables and frequencies and proportions for categorical variables. Fisher's exact test and Pearson's chi-square test were used to compare proportions. Wilcoxon rank-sum test was used to compare the continuous variables. OS and EFS were calculated using the Kaplan-Meier method. Differences between survival curves were analysed by Log-rank test. Cox-proportional hazard regression model http://www.selleckchem.com/products/VX-770.html was applied to estimate the hazard ratio (HR) and 95% confidence interval (CI). Two-sided tests were applied and results were considered significant when the P-value was